Bioactivity:

1. Deoxyshikonin may be a new drug candidate for wound healing and treatment of lymphatic diseases. 2. Deoxyshikonin enhances the ability of human dermal lymphatic microvascular endothelial cells (HMVEC-dLy) to undergo time-dependent in vitro cord formati

CAS nr:

43043-74-9

Purity:

98%

Molecular Weight:

272,3

SMILES:

CC(=CCCC1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)C

Formula:

C16H16O4

Pathway:

Metabolism,Chromatin/Epigenetic,Microbiology/Virology,Others

Target:

HIF/HIF Prolyl-Hydroxylase,HIF/HIF Prolyl-Hydroxylase,Antibacterial,Others